
Episode 098: Understanding MRD Testing in CLL
The Fellow on Call: The Heme/Onc Podcast
00:00
Understanding Measurable Residual Disease in CLL
This chapter explores Measurable Residual Disease (MRD) and its crucial role in assessing residual cancer cells post-treatment. It discusses detection methods like flow cytometry and molecular techniques, along with the clinical implications of MRD status in chronic lymphocytic leukemia.
Transcript
Play full episode